Genitourinary Cancers Care Team

Medical Oncology

Director of Clinical Research, Director of Cancer Drug Development, and Associate Director of Division of Hematology/Oncology

Benedito A Carneiro, MD, is a medical oncologist with research interests in developmental therapeutics, solid organ malignancies and genitourinary cancers. As director of Cancer Drug Development for the Lifespan Cancer Institute of Rhode Island Hospital, The Miriam Hospital and Newport Hospital, and associate director of the Division of Hematology/Oncology, Dr. Carneiro leads clinical trials with novel treatments for cancers of the kidney, bladder, prostate, lung, pancreas, colon and other solid tumors.  His research explores innovative immunotherapy and genomic-driven treatment strategies.

His work has been published in several peer-reviewed articles and book chapters. He is a member of many professional societies and scientific committees, including the American Society of Clinical Oncology, American Association of Cancer Research. Dr. Carneiro speaks English and Portuguese. 

Hematologist Oncologist

Andre Luiz De Souza, MD, is a hematologist/oncologist at Lifespan Cancer Institute whose clinical interests include kidney, bladder, testicular and prostate cancers. Dr. De Souza is a member of the American Society of Clinical Oncology and the American Society of Hematology. He speaks Portuguese and Spanish. 

Radiation Oncology

Clinical Director, Radiation Oncology

Thomas DiPetrillo, MD, is clinical director of radiation oncology at Rhode Island and The Miriam hospitals. He is a leading authority on a variety of radiation treatments for cancer, including intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy. DiPetrillo is a pioneer in the use of IMRT, a noninvasive procedure that allows physicians to pinpoint delivery of radiation therapy, resulting in better tumor control with less toxicity. He is also an expert in the use of HDR brachytherapy, a treatment that involves the use of a robotic arm to deliver a radioactive “seed” to a tumor. 

DiPetrillo is a graduate of the University of Vermont College of Medicine and completed his residency at New England Medical Center (now Tufts Medical Center). He is an associate professor of radiation oncology at The Warren Alpert Medical School of Brown University, and an adjunct associate professor at Tufts University School of Medicine.

Radiation Oncologist

Paul P. Koffer, MD, is a radiation oncologist at Lifespan Cancer Institute at Rhode Island Hospital. Dr. Koffer received his undergraduate degree in biophysics from the University of Pennsylvania. He earned his medical degree from Temple University School of Medicine in Philadelphia and completed his residency in radiation oncology at Tufts Medical Center, where he was appointed chief resident. Dr. Koffer’s research and academic interests include the stereotactic radiosurgery and assessment and management of cancer pain.

Surgical Oncology

Director, Minimally Invasive Urology Institute; Director, Genitourinary Oncology at The Miriam Hospital

Dragan Golijanin, MD, is a director of the Minimally Invasive Urology Institute and director of Genitourinary Oncology at The Miriam Hospital. He also serves as an associate professor of surgery (urology) at The Warren Alpert Medical School of Brown University. His areas of expertise include prostate cancer, kidney cancer, bladder cancer and testicular cancer. Golijanin is board certified in urology. He is the 2019 recipient of the Alan Podis MD Teaching Award. 

Golijanin earned his medical degree at the University of Belgrade. He completed residencies at the University of Rochester School of Medicine, University Clinical Center in Belgrade and Hadassah Medical Center. He completed fellowships in urologic oncology at Memorial Sloan-Kettering Cancer Center, Cornell University and Hadassah Medical Center. He was the first to publish on near-infrared real-time imaging in open laparoscopic and robotic surgery.

Learn more about Dr. Golijanin’s research on »

Director of Minimally Invasive Urologic Surgery

Gyan Pareek, MD, FACS is a director of the Minimally Invasive Urology Institute and director of the Kidney Stone Center at The Miriam Hospital. He is also a professor of surgery (urology) at The Warren Alpert Medical School of Brown University and Vice President of Operations at Brown Urology, Inc.  His areas of expertise include kidney stones, prostate cancer and benign prostatic hyperplasia. Dr. Pareek is board certified in urology. Dr. Pareek is the 2019 recipient of the Riesman Family Excellence in Teaching Award.

Pareek earned his medical degree from St. George’s University School of Medicine and completed his residency at Lenox Hill Hospital in New York. He also completed his laparoscopy and endourology fellowship at the University of Wisconsin. In 2006, Dr. Pareek was part of a team at The Miriam Hospital that performed the first robotic prostatectomy in southern New England.  He has held a number of leadership roles at the New England American Urological Association and the Rhode Island Urological Association.

Learn more about Dr. Pareek's research on »

Nurse/Nurse Practitioner

Jennifer Cunningham, NP
Nurse Practitioner

Jennifer Cunningham, NP is a nurse practitioner. She monitors and treats patients with chemotherapy, targeted and hormonal therapy, and provides supportive care and symptom management during treatment. Cunningham is a graduate of Providence College and Yale University.